ReviewNutrition & metabolism2026
Dietary intake of individual and total carotenoids in relation to overweight and obesity: findings from the PERSIAN cohort study.
Review in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework.Obesity pillars · 2026Review
- Dietary carotenoids and vitamin A are associated with lower gastric cancer risk and favorable inflammatory and oxidative stress biomarkers: an incident case- control study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDietary carotenoids may have independent positive impacts on a range of health-related outcomes such as obesity. The purpose of this study was to examine the associations between individual and total dietary carotenoids and the likelihood of being overweight or obese.
methodsDietary intakes of 4202 participants of the PERSIAN cohort study were investigated by a 237-item FFQ, and carotenoid intake was determined using the USDA food databases. Models of logistic regression were applied to assess the association between obesity and overweight and dietary intake of carotenoids after adjusting for confounders.
resultsHigher total carotenoid intake was associated with reduced risk of overweight (energy-adjusted OR: 0.647, 95% CI: 0.429-0.975, P = 0.037) and obesity (energy-adjusted OR: 0.395, 95% CI: 0.244-0.640, P < 0.001). Specific individual carotenoids, including β-carotene (OR: 0.510, 95% CI: 0.356-0.731, P < 0.001), lutein/zeaxanthin (OR: 0.479, 95% CI: 0.331-0.692, P < 0.001), and phytoene (OR = 0.450, 95% CI = 0.306-0.661, P < 0.001) exhibited stronger inverse associations compared to lycopene and astaxanthin.
conclusionDiets rich in specific carotenoids, particularly β-carotene, lutein, and phytoene, may reduce the risk of both overweight and obesity. Future research ought to examine the mechanisms behind the relations of carotenoids with public health issues.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.